$GBLX
GB SCIENCES INC Stock $gblx

$gblx Overview Financials Valuation SEC Filings Company Website

2020 Q3 Form 10-Q Financial Statement

#000143774920023849 Filed on November 13, 2020

Income Statement

Concept	2020 Q3	2020 Q2	2019 Q3
Revenue	$0.00	$0.00
YoY Change		-100.0%
Cost Of Revenue	$0.00	$0.00
YoY Change		-100.0%
Gross Profit	$0.00	$0.00
YoY Change		-100.0%
Gross Profit Margin
Selling, General & Admin	$491.8K	$515.3K	$1.291M
YoY Change	-61.91%	-75.06%	-66.08%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$2.580K	$13.03K	-$121.3K
YoY Change	-102.13%	-95.15%	-160.91%
% of Gross Profit
Operating Expenses	$491.8K	$515.3K	$1.291M
YoY Change	-61.91%	-75.06%	-66.08%
Operating Profit	-$491.8K	-$515.3K	-$1.291M
YoY Change	-61.91%	-71.04%	-61.93%
Interest Expense	$410.9K	$662.4K	$352.7K
YoY Change	16.5%	51.29%	-112.75%
% of Operating Profit
Other Income/Expense, Net	-$412.7K	-$959.6K	-$260.0K
YoY Change	58.71%	119.18%	-91.47%
Pretax Income	-$904.5K	-$1.475M	-$1.551M
YoY Change	-41.69%	-33.48%	-83.15%
Income Tax	$0.00	$0.00	-$57.39K
% Of Pretax Income
Net Earnings	-$805.5K	-$1.847M	-$2.683M
YoY Change	-69.98%	-23.27%	-72.45%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$2.871K	-$6.644K	-$10.62K
COMMON SHARES
Basic Shares Outstanding	280.5M
Diluted Shares Outstanding

Balance Sheet

Concept	2020 Q3	2020 Q2	2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$545.0K	$101.2K	$84.80K
YoY Change	542.71%	-28.36%	-97.1%
Cash & Equivalents	$545.0K	$101.2K	$70.68K
Short-Term Investments
Other Short-Term Assets	$2.016M	$57.06K	$1.537M
YoY Change	31.17%	-76.88%	79.42%
Inventory		$1.546M	$1.542M
Prepaid Expenses
Receivables		$192.5K	$187.2K
Other Receivables		$5.224M	$0.00
Total Short-Term Assets	$6.911M	$7.121M	$3.350M
YoY Change	106.27%	83.73%	-45.5%
LONG-TERM ASSETS
Property, Plant & Equipment	$31.28K	$5.360M	$10.42M
YoY Change	-99.7%	-77.19%	-50.07%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$5.767M	$91.50K	$14.09M
YoY Change	-59.07%	-92.6%	705.83%
Total Long-Term Assets	$7.343M	$7.253M	$26.49M
YoY Change	-72.28%	-72.73%	9.2%
TOTAL ASSETS
Total Short-Term Assets	$6.911M	$7.121M	$3.350M
Total Long-Term Assets	$7.343M	$7.253M	$26.49M
Total Assets	$14.25M	$14.37M	$29.84M
YoY Change	-52.23%	-52.82%	-1.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.347M	$2.712M	$1.621M
YoY Change	44.73%	9.91%	243.67%
Accrued Expenses	$1.205M	$1.189M	$748.1K
YoY Change	61.11%	83.65%	71.66%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$151.9K	$0.00
YoY Change
Long-Term Debt Due	$6.428M	$6.473M	$5.024M
YoY Change	27.95%	30.26%	337.4%
Total Short-Term Liabilities	$13.14M	$12.50M	$9.425M
YoY Change	39.4%	44.57%	358.37%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$3.500M	$3.650M
YoY Change	-100.0%	-42.26%	-42.46%
Other Long-Term Liabilities	$3.465M	$20.50K	$2.449M
YoY Change	41.47%	-86.09%
Total Long-Term Liabilities	$3.465M	$3.520M	$6.099M
YoY Change	-43.19%	-43.3%	-3.84%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.14M	$12.50M	$9.425M
Total Long-Term Liabilities	$3.465M	$3.520M	$6.099M
Total Liabilities	$16.60M	$16.02M	$24.55M
YoY Change	-32.38%	-32.05%	40.13%
SHAREHOLDERS EQUITY
Retained Earnings	-$100.1M	-$99.25M
YoY Change
Common Stock	$28.05K	$28.05K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$2.350M	-$1.649M	$14.32M
YoY Change
Total Liabilities & Shareholders Equity	$14.25M	$14.37M	$29.84M
YoY Change	-52.23%	-52.82%	-1.86%

Cashflow Statement

Concept	2020 Q3	2020 Q2	2019 Q3
OPERATING ACTIVITIES
Net Income	-$805.5K	-$1.847M	-$2.683M
YoY Change	-69.98%	-23.27%	-72.45%
Depreciation, Depletion And Amortization	$2.580K	$13.03K	-$121.3K
YoY Change	-102.13%	-95.15%	-160.91%
Cash From Operating Activities	$111.0K	-$323.8K	-$915.3K
YoY Change	-112.13%	-87.69%	-68.26%
INVESTING ACTIVITIES
Capital Expenditures	$0.00		-$36.49K
YoY Change	-100.0%		-101.77%
Acquisitions
YoY Change
Other Investing Activities	$597.7K		-$260.6K
YoY Change	-329.32%		-96.58%
Cash From Investing Activities	$597.7K	$0.00	-$297.1K
YoY Change	-301.16%	-100.0%	-94.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-115.6K	$273.3K	1.165M
YoY Change	-109.92%	-90.25%	-82.61%
NET CHANGE
Cash From Operating Activities	111.0K	-$323.8K	-915.3K
Cash From Investing Activities	597.7K	$0.00	-297.1K
Cash From Financing Activities	-115.6K	$273.3K	1.165M
Net Change In Cash	593.0K	-$50.54K	-47.00K
YoY Change	-1361.74%	-41.54%	-97.28%
FREE CASH FLOW
Cash From Operating Activities	$111.0K	-$323.8K	-$915.3K
Capital Expenditures	$0.00		-$36.49K
Free Cash Flow	$111.0K	-$323.8K	-$878.9K
YoY Change	-112.63%	-88.44%	-82.23%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
	dei	Document Period End Date DocumentPeriodEndDate	2020-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001165320
CY2020Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	281779436
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Registrant Name EntityRegistrantName	GB SCIENCES INC
	dei	Entity Shell Company EntityShellCompany	false
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	gblx	Accrued Interest Capitalized In Convertible Note Principal AccruedInterestCapitalizedInConvertibleNotePrincipal	223094
	gblx	Accrued Interest Capitalized In Convertible Note Principal AccruedInterestCapitalizedInConvertibleNotePrincipal
	gblx	Accrued Liabilites Forgiven AccruedLiabilitesForgiven	172500
	gblx	Accrued Liabilites Forgiven AccruedLiabilitesForgiven
	gblx	Cancelled Shares Issued To Consultant Value CancelledSharesIssuedToConsultantValue
	gblx	Cumulative Effect Of New Lease Standard CumulativeEffectOfNewLeaseStandard
	gblx	Cumulative Effect Of New Lease Standard CumulativeEffectOfNewLeaseStandard	7550
CY2020Q3	gblx	Debt Default Penalty DebtDefaultPenalty
CY2019Q3	gblx	Debt Default Penalty DebtDefaultPenalty
	gblx	Debt Default Penalty DebtDefaultPenalty	286059
	gblx	Debt Default Penalty DebtDefaultPenalty
	gblx	Default Penatly On Convertible Note Payable DefaultPenatlyOnConvertibleNotePayable	286059
	gblx	Default Penatly On Convertible Note Payable DefaultPenatlyOnConvertibleNotePayable
	gblx	Depreciation Capitalized In Inventory DepreciationCapitalizedInInventory	272267
	gblx	Depreciation Capitalized In Inventory DepreciationCapitalizedInInventory	273090
CY2019Q3	gblx	Exercise Of Warrants For Stock Value ExerciseOfWarrantsForStockValue	674302
	gblx	Exercise Of Warrants For Stock Value ExerciseOfWarrantsForStockValue	136081
	gblx	Exercise Of Warrants For Stock Value ExerciseOfWarrantsForStockValue	850478
	gblx	Increase Decrease In Accrued Liabilities Excluding Interest Payable IncreaseDecreaseInAccruedLiabilitiesExcludingInterestPayable	414130
	gblx	Increase Decrease In Accrued Liabilities Excluding Interest Payable IncreaseDecreaseInAccruedLiabilitiesExcludingInterestPayable	187133
	gblx	Induced Dividend From Exercise Of Warrants InducedDividendFromExerciseOfWarrants	17263
	gblx	Induced Dividend From Exercise Of Warrants InducedDividendFromExerciseOfWarrants	230025
CY2019Q3	gblx	Induced Dividend From Warrant Exercises InducedDividendFromWarrantExercises
	gblx	Induced Dividend From Warrant Exercises InducedDividendFromWarrantExercises
	gblx	Induced Dividend From Warrant Exercises InducedDividendFromWarrantExercises
	gblx	Operating Lease Interest Expense OperatingLeaseInterestExpense	1242
	gblx	Patent Filing And Drafting Costs Capitalized In Intangible Assets PatentFilingAndDraftingCostsCapitalizedInIntangibleAssets	320722
	gblx	Patent Filing And Drafting Costs Capitalized In Intangible Assets PatentFilingAndDraftingCostsCapitalizedInIntangibleAssets	67008
	gblx	Property Capitalized Under Operating Leases PropertyCapitalizedUnderOperatingLeases
	gblx	Property Capitalized Under Operating Leases PropertyCapitalizedUnderOperatingLeases	182624
	gblx	Stock Options Issued To Acquire Intangible Assets StockOptionsIssuedToAcquireIntangibleAssets	105000
	gblx	Stock Options Issued To Acquire Intangible Assets StockOptionsIssuedToAcquireIntangibleAssets
CY2020Q3	gblx	Working Capital Deficit WorkingCapitalDeficit	-6227642
CY2020Q1	gblx	Working Capital Deficit WorkingCapitalDeficit	-3884877
CY2020Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2346652
CY2020Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1913049
CY2020Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1205248
CY2020Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	813618
CY2020Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	97679001
CY2020Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	97271157
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	133806
	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	150000
	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	133806
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	105000
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	105000
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	32408
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	208809
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	132914
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	132914
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	748956
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	434750
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	153637853
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	280532686
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	275541602
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000
CY2020Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	280532686
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	275541602
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	28054
CY2020Q1	us-gaap	Common Stock Value CommonStockValue	27554
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	158404020
CY2020Q3	us-gaap	Assets Assets	14254064
CY2020Q1	us-gaap	Assets Assets	14352868
CY2020Q3	us-gaap	Assets Current AssetsCurrent	6910833
CY2020Q1	us-gaap	Assets Current AssetsCurrent	7000880
CY2020Q3	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	1997037
CY2020Q1	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	1755275
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	545020
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2406
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	545020
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	70678
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	151766
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	227758
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	694241
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	94317
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	542475
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-133441
	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	-101487
	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	213625
	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-104265
	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-462920
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-10602
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-1758120
CY2020Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	79488161
CY2020Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	15612
CY2020Q3	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	5766598
CY2020Q3	us-gaap	Cost Of Revenue CostOfRevenue
CY2019Q3	us-gaap	Cost Of Revenue CostOfRevenue
	us-gaap	Cost Of Revenue CostOfRevenue
	us-gaap	Cost Of Revenue CostOfRevenue
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	280000
CY2020Q3	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	9624
CY2020Q1	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	608580
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	76716
CY2020Q1	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	6185465
CY2020Q3	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	149221
CY2019Q3	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	23639
CY2020Q3	us-gaap	Due To Officers Or Stockholders Current DueToOfficersOrStockholdersCurrent	710075
CY2020Q1	us-gaap	Due To Officers Or Stockholders Current DueToOfficersOrStockholdersCurrent	586512
CY2020Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0
CY2019Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.01
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.01
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.02
CY2020Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	17611
CY2020Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	12287
CY2020Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1545355
CY2020Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1128702
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-124158
CY2020Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	491818
CY2019Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1291232
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1007071
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3082697
CY2020Q3	us-gaap	Gross Profit GrossProfit
CY2019Q3	us-gaap	Gross Profit GrossProfit
	us-gaap	Gross Profit GrossProfit
	us-gaap	Gross Profit GrossProfit
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-2407252
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-3654927
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-904514
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1551261
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2379378
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3654927
CY2020Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-923548
CY2019Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1493869
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-2407252
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-3654927
CY2020Q3	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	0
CY2019Q3	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.01
	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.01
	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.01
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-244906
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-1812563
CY2020Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	118090
CY2019Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-1434737
CY2020Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	0
CY2019Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	0
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	0
CY2020Q3	us-gaap	Liabilities Liabilities	16603635
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14352868
CY2020Q3	us-gaap	Liabilities Current LiabilitiesCurrent	13138475
CY2020Q1	us-gaap	Liabilities Current LiabilitiesCurrent	10885757
CY2020Q3	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	1348111
CY2020Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	1406080
CY2020Q3	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	3465160
CY2020Q1	us-gaap	Liabilities Liabilities	14441362
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14254064
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-0.01
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	19034
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-57392
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	27874
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit
	us-gaap	Income Taxes Paid IncomeTaxesPaid
	us-gaap	Income Taxes Paid IncomeTaxesPaid
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	262881
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	304550
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	27874
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	123563
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	325925
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	190695
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-180060
CY2020Q3	us-gaap	Interest Expense InterestExpense	410946
CY2019Q3	us-gaap	Interest Expense InterestExpense	352736
	us-gaap	Interest Expense InterestExpense	1082874
	us-gaap	Interest Expense InterestExpense	664937
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	26804
	us-gaap	Interest Paid Net InterestPaidNet
	us-gaap	Interest Paid Net InterestPaidNet	332167
CY2020Q3	us-gaap	Interest Payable Current InterestPayableCurrent	479255
CY2020Q1	us-gaap	Interest Payable Current InterestPayableCurrent	366865
CY2020Q3	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.17
CY2020Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	3555605
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	157671
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3967798
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	259158
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	3754173
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	597658
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-554782
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	701923
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-91862
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-212854
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3546457
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-202252
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-1788337
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-805458
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-2683041
	us-gaap	Net Income Loss NetIncomeLoss	-2652158
	us-gaap	Net Income Loss NetIncomeLoss	-5089709
CY2020Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest
CY2019Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-245565
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-377781
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-805458
CY2019Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2683041
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2652158
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5089709
CY2020Q3	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-923548
CY2019Q3	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-1493869
	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-2407252
	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-3654927
CY2020Q3	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	118090
CY2019Q3	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	-1189172
	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	-244906
	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	-1434782
CY2019Q3	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	550001
	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	550001
CY2020Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-412696
CY2019Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-260029
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1372307
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-572230
CY2020Q3	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	4350000
CY2020Q1	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	5224423
CY2020Q3	us-gaap	Notes Payable Current NotesPayableCurrent	6428278
CY2020Q1	us-gaap	Notes Payable Current NotesPayableCurrent	5054728
CY2020Q3	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent
CY2020Q1	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	151923
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-491818
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1291232
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1007071
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3082697
	us-gaap	Operating Lease Cost OperatingLeaseCost	3243
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2001
CY2020Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1750
CY2019Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	92707
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3374
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	92707
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	175000
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	15121
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	166027
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	91862
CY2020Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	18776
CY2020Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	18776
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Reclassifications</div></div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">Certain reclassifications have been made to the comparative period amounts to conform to the current period presentation. Certain items on the unaudited balance sheets and statements of operations and cash flows have been reclassified to conform with current period presentation. The assets, liabilities, income, and cash flows of GB Sciences Louisiana, LLC, GB Sciences Nevada, LLC, GB Sciences Las Vegas, LLC, and GB Sciences Nopah, LLC have been reclassified to discontinued operations due to the sale of the Company's Louisiana cultivation and extraction facility (Note <div style="display: inline; font-style: italic; font: inherit;">10</div>) and the pending sale of the Company's Nevada cultivation and extraction facilities (Note <div style="display: inline; font-style: italic; font: inherit;">11</div>).</div></div></div></div></div>
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	150000
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	2600000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	550225
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	125000
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit
	us-gaap	Proceeds From Sale And Collection Of Notes Receivable ProceedsFromSaleAndCollectionOfNotesReceivable	701923
	us-gaap	Proceeds From Sale And Collection Of Notes Receivable ProceedsFromSaleAndCollectionOfNotesReceivable
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	151202
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	944975
CY2020Q3	us-gaap	Profit Loss ProfitLoss	-805458
CY2019Q3	us-gaap	Profit Loss ProfitLoss	-2928606
	us-gaap	Profit Loss ProfitLoss	-2652158
	us-gaap	Profit Loss ProfitLoss	-5467490
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	31278
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	37821
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	151923
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-100056626
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-97387205
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	280000
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	478696
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	-1649113
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	-2349571
CY2020Q3	us-gaap	Revenues Revenues
CY2019Q3	us-gaap	Revenues Revenues
	us-gaap	Revenues Revenues
	us-gaap	Revenues Revenues
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	15610838
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	14315663
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	-88494
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	17155999
	us-gaap	Share Based Compensation ShareBasedCompensation
	us-gaap	Share Based Compensation ShareBasedCompensation	341724
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	13366334
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.28
CY2019Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	110000
CY2020Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	620856
CY2020Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	592982
	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.  The Company regularly evaluates estimates and assumptions related to allowances for doubtful accounts, inventory valuation and standard cost allocations, valuation of initial right-of-use assets and corresponding lease liabilities, valuation of beneficial conversion features in convertible debt, valuation of the assets and liabilities of discontinued operations, stock-based compensation expense, purchased intangible asset valuations, deferred income tax asset valuation allowances, uncertain tax positions, litigation and other loss contingencies.  These estimates and assumptions are based on current facts, historical experience and various other factors that the Company believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of costs and expenses that are <div style="display: inline; font-style: italic; font: inherit;">not</div> readily apparent from other sources. The actual results the Company experiences <div style="display: inline; font-style: italic; font: inherit;"> may </div>differ materially and adversely from these estimates.</div></div></div></div></div>
CY2020Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	280532686
CY2019Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	252700538
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	279257607
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	248392203

Files In Submission

Name	View Source	Status
0001437749-20-023849-index-headers.html	Edgar Link	pending
0001437749-20-023849-index.html	Edgar Link	pending
0001437749-20-023849.txt	Edgar Link	pending
0001437749-20-023849-xbrl.zip	Edgar Link	pending
ex_206376.htm	Edgar Link	pending
ex_206377.htm	Edgar Link	pending
ex_206378.htm	Edgar Link	pending
ex_206379.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
gblx-20200930.xml	Edgar Link	completed
gblx-20200930.xsd	Edgar Link	pending
gblx-20200930_cal.xml	Edgar Link	unprocessable
gblx-20200930_def.xml	Edgar Link	unprocessable
gblx-20200930_lab.xml	Edgar Link	unprocessable
gblx-20200930_pre.xml	Edgar Link	unprocessable
gblx20200930_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GBLX
GB SCIENCES INC Stock $gblx

2020 Q3 Form 10-Q Financial Statement

#000143774920023849 Filed on November 13, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GBLX GB SCIENCES INC Stock $gblx

2020 Q3 Form 10-Q Financial Statement

#000143774920023849 Filed on November 13, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GBLX
GB SCIENCES INC Stock $gblx